| 000 | 01301 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513110657.0 | ||
| 264 | 0 | _c19970124 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/0732-8893(95)00149-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCormican, M G | |
| 245 | 0 | 0 |
_aActivity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cJan 1996 |
||
| 300 |
_a59-60 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEnterococcus _xdrug effects |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 650 | 0 | 4 |
_aVirginiamycin _xtherapeutic use |
| 700 | 1 | _aJohnson, D M | |
| 700 | 1 | _aJones, R N | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 24 _gno. 1 _gp. 59-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0732-8893(95)00149-2 _zAvailable from publisher's website |
| 999 |
_c8980210 _d8980210 |
||